Dermata Therapeutics Warrant Stock Market Value
| DRMAW Stock | USD 0.02 0.01 96.08% |
| Symbol | Dermata |
Dermata Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dermata Therapeutics. If investors know Dermata will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dermata Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Dermata Therapeutics is measured differently than its book value, which is the value of Dermata that is recorded on the company's balance sheet. Investors also form their own opinion of Dermata Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Dermata Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dermata Therapeutics' market value can be influenced by many factors that don't directly affect Dermata Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dermata Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dermata Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dermata Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Dermata Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Dermata Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Dermata Therapeutics.
| 12/17/2024 |
| 03/17/2025 |
If you would invest 0.00 in Dermata Therapeutics on December 17, 2024 and sell it all today you would earn a total of 0.00 from holding Dermata Therapeutics Warrant or generate 0.0% return on investment in Dermata Therapeutics over 90 days. Dermata Therapeutics is related to or competes with Dermata Therapeutics. Dermata Therapeutics is entity of United States More
Dermata Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Dermata Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Dermata Therapeutics Warrant upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 20.17 | |||
| Information Ratio | 0.153 | |||
| Maximum Drawdown | 111.95 | |||
| Value At Risk | (27.01) | |||
| Potential Upside | 40.94 |
Dermata Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Dermata Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Dermata Therapeutics' standard deviation. In reality, there are many statistical measures that can use Dermata Therapeutics historical prices to predict the future Dermata Therapeutics' volatility.| Risk Adjusted Performance | 0.1389 | |||
| Jensen Alpha | 2.93 | |||
| Total Risk Alpha | 6.07 | |||
| Sortino Ratio | 0.1685 | |||
| Treynor Ratio | (1.01) |
Dermata Therapeutics Backtested Returns
Dermata Therapeutics is out of control given 3 months investment horizon. Dermata Therapeutics secures Sharpe Ratio (or Efficiency) of 0.13, which denotes the company had a 0.13 % return per unit of risk over the last 3 months. We were able to analyze thirty different technical indicators, which can help you to evaluate if expected returns of 3.17% are justified by taking the suggested risk. Use Dermata Therapeutics Downside Deviation of 20.17, mean deviation of 14.26, and Coefficient Of Variation of 673.26 to evaluate company specific risk that cannot be diversified away. Dermata Therapeutics holds a performance score of 10 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -3.25, which means a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Dermata Therapeutics are expected to decrease by larger amounts. On the other hand, during market turmoil, Dermata Therapeutics is expected to outperform it. Use Dermata Therapeutics maximum drawdown and the relationship between the expected short fall and period momentum indicator , to analyze future returns on Dermata Therapeutics.
Auto-correlation | -0.67 |
Very good reverse predictability
Dermata Therapeutics Warrant has very good reverse predictability. Overlapping area represents the amount of predictability between Dermata Therapeutics time series from 17th of December 2024 to 31st of January 2025 and 31st of January 2025 to 17th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Dermata Therapeutics price movement. The serial correlation of -0.67 indicates that around 67.0% of current Dermata Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.67 | |
| Spearman Rank Test | -0.41 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Dermata Therapeutics lagged returns against current returns
Autocorrelation, which is Dermata Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Dermata Therapeutics' stock expected returns. We can calculate the autocorrelation of Dermata Therapeutics returns to help us make a trade decision. For example, suppose you find that Dermata Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Dermata Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Dermata Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Dermata Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Dermata Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Dermata Therapeutics Lagged Returns
When evaluating Dermata Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Dermata Therapeutics stock have on its future price. Dermata Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Dermata Therapeutics autocorrelation shows the relationship between Dermata Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Dermata Therapeutics Warrant.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Dermata Stock Analysis
When running Dermata Therapeutics' price analysis, check to measure Dermata Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dermata Therapeutics is operating at the current time. Most of Dermata Therapeutics' value examination focuses on studying past and present price action to predict the probability of Dermata Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dermata Therapeutics' price. Additionally, you may evaluate how the addition of Dermata Therapeutics to your portfolios can decrease your overall portfolio volatility.